Our studies identified a mechanism by which Mmp2 modulates antitumor activity: ligation of TLR2/4 on APCs promotes tumor infiltration of myelosuppressive populations while reducing tumor infiltrating CD4+ and CD8+ T cells, NK cells, and CD103+ DCs. This evidence concerns the gene CD8A and neoplasm.